New AACR data highlight stenoparib’s potential in colorectal cancer through WNT pathway modulationThe Stenoparib-DRP® companion ...
Ongoing Phase 2 study in metastatic colorectal cancer (mCRC) demonstrates early clinical and biomarker activity with leronlimab in combination ...
New research has identified a protein that could serve as both a biomarker and therapeutic target to weaken stem-like cancer ...
Unlike many cancers, colorectal cancer has become more lethal for people at younger ages. Doctors are sleuthing out why.
Meredith Hullar, principal staff scientist working with Ulrike (Riki) Peters, PhD, MPH, and Amanda Phipps, PhD, MPH, and their teams, sought to characterize connections between the microbiome and ...
WASHINGTON (AP) — Colorectal cancer is a threat not just to older adults but increasingly to young men and women, too. It’s now the top cancer killer of Americans younger than 50. The deaths of ...